BGAI
HRMY icon

Bruce G. Allen Investments’s Harmony Biosciences HRMY Stock Holding History

Bruce G. Allen Investments’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112 Sell
4
-11
-73% -$361 ﹤0.01% 1078
2025
Q4 		$561 Hold
15
– – ﹤0.01% 952
2025
Q3 		$413 Buy
15
+3
+25% +$103 ﹤0.01% 994
2025
Q2 		$379 Buy
+12
New +$386 ﹤0.01% 1001

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bruce G. Allen Investments's HRMY Position: Q1 2026 in Review

Bruce G. Allen Investments reduced its Harmony Biosciences (HRMY) stake by 73% in Q1 2026, selling an estimated $361 and leaving 4 shares worth $112. The position accounts for ﹤0.01% of the portfolio, ranked #1078.

Bruce G. Allen Investments first reported a position in HRMY in Q2 2025 and has held it in 4 quarters since. The position peaked at $561 in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Bruce G. Allen Investments held 4 shares of Harmony Biosciences worth $112 as of Q1 2026.
  • Bruce G. Allen Investments sold 11 Harmony Biosciences shares in Q1 2026, an estimated $361.
  • Harmony Biosciences made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q1 2026, its #1078 holding.
  • Bruce G. Allen Investments first reported a position in Harmony Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Bruce G. Allen Investments's Harmony Biosciences position peaked at $561 in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.